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The superficial zone (SZ) of articular cartilage is critical in main-
taining tissue function and homeostasis and represents the site of
the earliest changes in osteoarthritis. Mechanisms that regulate
the unique phenotype of SZ chondrocytes and maintain SZ integ-
rity are unknown. We recently demonstrated that expression of
the chromatin protein high mobility group box (HMGB) protein 2
is restricted to the SZ in articular cartilage suggesting a transcrip-
tional regulation involving HMGB2 in SZ. Here, we show that an
interaction between HMGB2 and the Wnt/-catenin pathway reg-
ulates the maintenance of the SZ. We found that the Wnt/-catenin
pathway is active specifically in the SZ in normal mouse knee joints
and colocalizes with HMGB2. Both Wnt signaling and HMGB2
expression decrease with aging in mouse joints. Our molecular
studies show that HMGB2 enhances the binding of Lef-1 to its
target sequence and potentiates transcriptional activation of the
Lef-1--catenin complex. The HMG domain within HMGB2 is crucial
for interaction with Lef-1, suggesting that both HMGB2 and
HMGB1 may be involved in this function. Furthermore, conditional
deletion of -catenin in cultured mouse chondrocytes induced
apoptosis. These findings define a pathway where protein inter-
actions of HMGB2 and Lef-1 enhance Wnt signaling and promote
SZ chondrocyte survival. Loss of the HMGB2-Wnt signaling inter-
action is a new mechanism in aging-related cartilage pathology.
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Articular cartilage is a tissue that provides biomechanical prop-erties that allow near frictionless joint movement and disper-
sion of mechanical loads. Cartilage is composed of a single cell
lineage but differences in the organization, phenotype and function
of cells in the various layers of cartilage have been recognized (1–4).
The superficial zone (SZ) is the most unique. SZ cells produce
lubricin, also termed proteoglycan-4 (PRG4) or superficial zone
protein (SZP), an important joint lubricant (5–7), and are more
responsive to stimulation by catabolic cytokines such as IL-1 (8).
Recent studies also suggest that the SZ contains cells that express
mesenchymal stem cell markers (9–11).
Articular cartilage is among the tissues that undergo profound
aging-related changes and aging represents themajor risk factor for
osteoarthritis (OA), the most prevalent joint disease (12). Aging-
related changes in cartilage include reduced cellularity, increased
apoptosis and altered cellular responses to growth factors, cytokines
and mechanical stress (13–15). Cartilage changes in aging and OA
begin in the SZ and once the SZ is disrupted this is followed by
progressive erosion of the remaining cartilage layers (16).
To address mechanisms that maintain the unique phenotype of
SZ cells we performed gene expression analyses and observed that
expression of the chromatin protein HMGB2 is restricted to the SZ
(17). Joint aging in humans and mice leads to loss of HMGB2
expression and this is correlated with the onset of OA-like changes.
Mice deficient inHmgb2 develop early onset and more severe OA,
and this is associated with a reduction in cartilage cellularity
attributable to increased cell death (17).
Wnt proteins are secreted factors that regulate cell proliferation
and differentiation during early stages of chondrogenesis (18, 19).
Overexpression of -catenin in prechondrogenic cells inhibits overt
chondrocytic differentiation (20) and overexpression in chick limb
buds accelerates hypertrophic differentiation (21). In contrast,
inhibition of -catenin signaling by overexpression of Frzb-1, dom-
inant negative Wnt receptors, results in delayed maturation (22).
Homozygous deletion of -catenin is embryonic lethal but condi-
tional deletion in cartilage was associated with delayed chondrocyte
hypertrophy and reduced chondrocyte proliferation in growth
plates (23). Conditional mutant mice deficient in Wnt/-catenin
signaling displayed a defective flat cell layer normally abutting the
synovial cavity and markedly reduced levels of PRG4/SZP (24).
This supports the importance of Wnt signaling in skeletal devel-
opment and early stages of chondrocyte differentiation.
Recent studies indicate that Wnt signaling has a role in adult
articular cartilage. Increased Wnt signaling due to loss of sFRPS
function represents a risk factor for OA (25). Similarly, overexpres-
sion of -catenin in chondrocytes stimulates the expression of
matrix degradation enzymes (26). However, Wnt signaling also
contributes to differentiation andmaintenance of articular cartilage
chondrocytes. Inhibition of -catenin signaling by transgenic over-
expression of its intracellular antagonist ICAT results in progressive
SZ degradation and development ofOA (27). These studies suggest
that the precise temporal and spatial activation of Wnt signaling in
articular cartilage determines its homeostatic versus pathogenic
effects.
Taken together, these reports on Wnt/-catenin and our obser-
vations on HMGB2 suggest possible interactions in the mainte-
nance of the SZ in adult cartilage. Here, we define a molecular
mechanism by which HMGB2 and -catenin regulate cartilage SZ
integrity.
Results
-Catenin Signaling Is Activated in the SZ of Articular Cartilage and
Decreases with Aging. -catenin is an important regulator of chon-
drocyte maturation in growth plate and its expression and function
during skeletal development have been characterized (19, 21, 28).
To analyze -catenin in adult cartilage we used the TOPGAL
transgenic mouse model where the -galactosidase gene is under
the control of a LEF/TCF and -catenin inducible promoter and
allows direct detection of cells and tissues with activeWnt signaling
(29).Wnt/-catenin signaling has been reported to be active at early
stages during joint formation and to remain active and prominent
at later stages in small and large joints (24). In 1-month-old
TOPGALmice, we detected -galactosidase activity in all zones of
articular cartilage. At 3 months with joint maturation it became
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more restricted to the cartilage surface (Fig. 1A). At this stage,
-galactosidase protein was expressed in the SZ of articular carti-
lage inmeniscus but not in synovium (Fig. 1B). Because this pattern
is similar to that of HMGB2 (17), we performed double immuno-
fluorescence assay, and verified that most SZ cells express both
HMGB2 and -galactosidase (Fig. 1C).
Articular cartilage in C57BL/6J mice undergoes aging-related
changes that are similar to osteoarthritis joint pathology (30), and
this was also observed in TOPGALmice on CD1 background (Fig.
2). At 6 months of age articular cartilage had normal appearance,
and HMGB2 and -galactosidase positive cells were present in the
superficial cell layers. At 12 months of age there was a reduction in
cartilage thickness and cellularity and surface irregularities were
prominent in the central weight-bearing areas of the tibial plateau.
At 12 months HMGB2 and -galactosidase were both absent in the
SZ in the weight bearing areas, andHMGB2was completely absent
in all regions of articular cartilage by 18months (Fig. 2). In contrast,
-galactosidase was enhanced in themid and deep zone, in calcified
cartilage, subchondral bone and in osteophytes at 18months. These
findings demonstrate a correlated aging-related loss of HMGB2
and -catenin signaling in the SZ of articular cartilage and this is
associated with OA-like pathology.
Functional Interactions of -Catenin and HMGB2. The in vivo colo-
calization of HMGB2 and Wnt/-catenin activity (Fig. 1) and the
correlation of their loss in OA-like pathology suggest interaction of
HMGB2 and Wnt/-catenin in the SZ. To study this in detail, we
performed luciferase-reporter assays. Using cyclin D1 promoter
(962CD1) (31), -catenin transfection caused the expected in-
crease in luciferase activity in both SW1353 chondrosarcoma cells
and 293T kidney epithelial cells (Fig. 3 A and B). Transfection of
HMGB2 (32) did not change luciferase activity but cotransfection
of HMGB2 and -catenin resulted in synergistic enhancement in
SW1353 chondrosarcoma cells (Fig. 3A); this synergy was not
observed in 293T kidney epithelial cells (Fig. 3B). Similar differ-
ences between cell types were obtained using the TOPflash pro-
moter, which contains multiple repeats of the -catenin-TCF/LEF
consensus sequences (33) (Fig. 3 C and D). The synergistic activity
of HMGB2 and -catenin was also seen in chondrogenic ATDC5
cells. Transfection of the FOPflash promoter with a mutated Lef-1
binding site showed no activity (Fig. 3E) but the activity of
TOPflash promoter was enhanced byHMGB2 in a dose-dependent
manner under -catenin transfection (Fig. 3F). These experiments
demonstrate synergistic interaction of -catenin and HMGB2 in
enhancing Lef-1 responsive promoters, specifically in chondrogenic
cell types.
Physical Interactions of HMGB2 and Lef-1. To examine molecular
interactions between -catenin, Lef-1 and HMGB2, GST-pull
down assays were performed using bacterially expressed GST-
HMGB2, -catenin and Lef-1 and in vitro-translated HMGB2,
-catenin and Lef-1 (34). We observed that in vitro-translated
HMGB2 bound GST-Lef-1, but not GST--catenin (Fig. 4A). The
results from the reverse experiment showed that in vitro-translated
Lef-1 interacted with GST-HMGB2 and GST--catenin (Fig. 4B).
When in vitro-translated -catenin protein was incubated with
GST-HMGB2 and GST-Lef-1, only GST-Lef-1 but not GST-
HMGB2 was pulled down (Fig. S1). This indicates a specific
interaction between HMGB2 and Lef-1, leading to enhanced
transcriptional activation of the Lef-1--catenin complex.
Interaction Domains of HMGB2 and Lef-1. To define the Lef-1
interaction domain within HMGB2, in vitro GST pull-down assays
were performed using GST-Lef-1 and HMGB2 deletion mutants
(A-box, B-box, acidic tail) as shown in Fig. S2A. The results
demonstrated that none of these 3 HMGB2 mutants interacts with
Lef-1 (Fig. S2B). Then we constructed A-box and B-box domains
with linker regions and found that both bind Lef-1 (Fig. S2B). Delta
box, which contains linker and acidic tail but not A-box or B-box,
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Fig. 1. Active Wnt signaling and correlation with HMGB2 expression in the
articular cartilage SZ. (A) Immunohistochemistry was performed with -ga-
lactosidase antibody on knee joint sections from 1 and 3-month-old TOPGAL
mice. Between 1 and 3 months of age the -galactosidase positive cells
become more restricted to the superficial cell layers in articular cartilage. (B)
-galactosidase (-Gal) positive cells are found in articular cartilage and
meniscus, whereas synovium is negative. Safranin O staining of the adjacent
section. AC, articular cartilage; M, meniscus; S, synovium. X100. (C) HMGB2
and -galactosidase expression by immunofluorescence assay. Colocalization
of HMGB2 and -galactosidase (-Gal) positive cells is found in the SZ in
articular cartilage at 3 months of age (arrowheads). Hoechst dye 33258 was
used to stain nuclei. (Magnification: 400.)
Fig. 2. HMGB2 and -galactosidase expression during aging in TOPGAL
mice. Safranin-O stained sections of joints from TOPGAL mice show normal
cartilage at 6 months, reduced thickness and cellularity at 12 and 18 months.
HMGB2 and-galactosidase (-Gal) are detected by immunohistochemistry at
6months in the articular cartilage surface.At 12months bothare absent in the
weight bearing areas, and HMGB2 is completely absent in the articular carti-
lage by 18months. In contrast, at 18 months -galactosidase becomes detect-
able in all other zonesof articular cartilageexcept for the SZ (arrowheads). AC,
articular cartilage; M, meniscus; OP, osteophyte. X100.
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did not interact with Lef-1. These results indicate that A-box or
B-box together with the linker region are required for HMGB2
binding to Lef-1.
Next we determined the domains in Lef-1 that are required for
interaction with HMGB2. GST pull-down assays were performed
with GST-HMGB2 and Lef-1 deletion mutant plasmids (FL,
N113, N295, N113-C102) (35). The results showed that
GST-HMGB2 could pull down Lef-1 FL (Fig. 4B), Lef-1 N113
andLef-1N295 but not Lef-1N113-C102 (Fig. S2C), indicating
that the HMG domain in Lef-1 is responsible for the physical
interaction with HMGB2.
DNA Binding Interactions of HMGB2 and Lef-1. To understand how
the HMGB2-Lef-1 interaction contributes to Wnt/-catenin activ-
ity, we examined whether the interaction affects Lef-1 DNA
binding. Gel shift assays were performed to determine binding
specificity and interactions of HMGB2 and Lef-1. We prepared
oligonucleotide probes with Lef-1 binding sites (cyclin D1 and
TOP) and a probe with a mutated Lef-1 binding site (FOP) as
described in ref. 36. Using nuclear extracts of Lef-1 transfected
SW1353 chondrosarcoma cells, we detected binding of Lef-1 to
both cyclin D1 and TOP probes, and this binding was enhanced by
the addition of purified HMGB2 (Fig. 4C). In contrast, no binding
was detected on the FOP probe. HMGB2 did not interact with
cyclin D1 and TOP probes without overexpressed Lef-1.
c-Jun is a target gene for the -catenin-Tcf/Lef transcriptional
complex (37), and Wnt signaling induces c-Jun expression in
chondrocytes (38). We also detected binding of Lef-1 to c-Jun
probes in SW1353 cells in the presence of Lef-1, and this binding
was potentiated by the addition ofHMGB2 protein (Fig. S3). These
results suggest that interaction between HMGB2 and Lef-1 en-
hances DNA binding affinity of Lef-1, to enhance Wnt/-catenin
signaling.
HMGB2 and Wnt/-Catenin Target Gene Expression. To examine
whether the interaction between HMGB2 and Lef-1 potentiates
Wnt/-catenin signaling activity, we examined Wnt/-catenin sig-
naling in WT and Hmgb2/ chondrocytes using SuperTOPflash,
which contains 8 TCF/LEF binding sites and the corresponding
negative control vector SuperFOPflash (39). We did not detect a
difference in luciferase activity between two groups when the cells
were unstimulated; however, in response to stimulation with re-
combinant Wnt3a luciferase activity was increased. Importantly,
this activation was significantly lower in Hmgb2/ chondrocytes
than in WT chondrocytes (Fig. 5A).
To further examine this, we analyzed levels of Wnt/-catenin
targets genes. HMGB2 was reduced by siRNA in immature murine
articular chondrocytes, which strongly express endogenous
HMGB2 (17) (Fig. 5B). Quantitative PCR shows that HMGB2
siRNA reduced cyclin D1 mRNA expression. Additional Wnt/-
catenin target genes, Gli3 and Frizzled 2 (Fzd2), which are ex-
pressed in articular cartilage (26, 40), were also reduced byHMGB2
siRNA, whereas PRG4/SZP that is expressed in murineHmgb2/
chondrocytes andWT chondrocytes was unaffected (17) (Fig. 5C).
To verify that HMGB2 does bind to targets of Lef1/-catenin
genes, we used chromatin immunoprecipitation assay.We observed
that HMGB2 can facilitate binding affinity of Lef-1 to the human
Gli3 enhancer (R2) (Fig. 5 D and E), which shows strong activity
among highly conserved noncoding DNA regions that contained
Tcf/Lef binding sequence within human Gli3 locus (R1–4) (41).
These results further support our notion that HMGB2 potentiates
Wnt/-catenin activity.
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Fig. 3. Synergy ofHMGB2and-catenin. HMGB2and
-catenin (CA) were cotransfected with the cyclin D1
(CD1) (A and B) and TOPflash reporter genes (C–F) in
SW1353 cells (A and C) and 293T cells (B and D), and
luciferase assay was performed after 24 h. In SW1353
cells, HMGB2 enhances luciferase activity when co-
transfected with -catenin (A and C), whereas this
synergistic effect is not seen in 293T cells (B andD). This
synergistic effect is also foundwith TOPflash in a dose-
dependentmanner (F), but not with FOPflash reporter
genes in ATDC5 cells (E) (*, P  0.05).
Lef-1
HMGB2
- - - - - - + + + + + +
- + - + - + - + - + - +
CD1 TOP FOP CD1 TOP FOP
- Free probe
- Lef-1
Probe
- N.S.
- N.S.
C
A
Lef-1HMGB2
BGST
- C
A
GS
T
Inp
ut
GS
T-L
ef-
1
GS
T
Inp
ut
GS
T-H
MG
B2
GS
T
Inp
ut
GS
T-
CA
Fig. 4. GST-pull down assay for -catenin (CA), Lef-1 and HMGB2. (A) In
vitro-translated HMGB2 interacts with GST-Lef-1, but not with GST--catenin.
(B) In vitro-translated Lef-1 interacts with both GST--catenin and GST-
HMGB2. (C) DNA binding interactions of HMGB2 and Lef-1 by EMSA. Using
nuclear extracts of SW1353 cells transfected with Lef-1, binding of Lef-1 with
both cyclin D1 (CD1) and TOP probes was detected. This was enhanced by the
additionofHMGB2protein (1g). In contrast, nobindingwas detectedon the
FOP probe. N.S., nonspecific.
Taniguchi et al. PNAS  September 29, 2009  vol. 106  no. 39  16819
M
ED
IC
A
L
SC
IE
N
CE
S
Loss of -Catenin Signaling Results in Chondrocyte Apoptosis. To
further test the functional significance of -catenin signaling we
conditionally inactivated -catenin. Chondrocytes were isolated
from knee and hip cartilage of -catenin floxed mice (Ctnnb1flox/
flox), infected with adenovirus-GFP-Cre and cultured for 72 h.
Immunofluorescence analysis of GFP demonstrated effective ad-
enoviral transduction (Fig. 6A). -catenin protein levels were
reduced with increasing amounts of adenovirus-GFP-Cre in
Ctnnb1flox/flox chondrocytes (Fig. 6B). Next, chondrocytes from
Ctnnb1flox/flox mice with or without adenovirus-GFP-Cre infection
were analyzed by flow cytometry for viability and the apoptosis
marker Annexin V. Upon adenovirus-GFP-Cre infection there was
a significant increase in apoptotic cells (Fig. 6C) without addition
of apoptosis inducers.When the chondrocytes were stimulated with
anti-Fas antibody CD95 and proteasome inhibitor MG132 (17), a
higher percentage of apoptotic chondrocytes was found after
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Fig. 5. Wnt/-catenin signaling inWT andHmgb2/
chondrocytes. (A) SuperTOPflash or SuperFOPflash re-
porter genes were transfected into murine WT or
Hmgb2/ chondrocytes. Upon addition of recombi-
nant Wnt3a, stronger luciferase activity was found in
WT chondrocytes compared with Hmgb2/ chondro-
cytes. SuperFOPflash vector was used as negative con-
trol (*, P 0.01). HMGB2 siRNA reducesWnt/-catenin
target genes in articular chondrocytes. (B) Murine
chondrocytes were transfected by oligo-siRNA nega-
tive control (N/C) or HMGB2 and cultured for 48 h,
followed by measurement of HMGB2 by Western blot
analysis. HMGB2 siRNA specifically and efficiently
down-regulated protein levels of HMGB2. (C) mRNA
levels of Wnt/-catenin target genes were measured
by real-time PCR. The expression levels of cyclin D1
(CD1), Gli3 and Fzd2 but not PRG4/SZPwere reduced in
chondrocytes with HMGB2 siRNA. (D) Schematic rep-
resentation of the human GLI3 locus. Gray indicates
the Gli3 gene, and Tcf/Lef-binding sites as putative
enhancers are depicted in red (R1–4). (E) Chromatin
immunoprecipitation assay shows that HMGB2 poten-
tiates bindingaffinity of Lef-1 onhumanGli3 enhancer
within R2 (Upper). Sequences not predicted to contain
Tcf/Lef-1 binding sites upstreamof the Exon1werenot
pulled down (Lower). IP, immunoprecipitation.
Fig. 6. Conditional inactivation of -catenin and
chondrocyte survival.CAflox/flox chondrocyteswere in-
fected with GFP-Cre adenovirus and cultured for 72 h.
(A) Immunofluorescence analysis shows GFP expres-
sion in infected cells. (B) Western blot shows reduction
in -catenin protein levels with increasing amounts of
GFP-Cre adenovirus (Ad-GFP-Cre). (C andD) FACS anal-
ysis for annexin V and propidium iodide (PI) staining.
GFP-Cre adenovirus infected cultures showed a higher
percentage of apoptotic chondrocytes compared with
noninfected (Con) cells in the absence or presence of
anti-Fas antibody CD95 (1 g/mL) andMG132 (20 M).
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adenovirus-GFP-Cre infection compared with control (Fig. 6D).
Thus, -catenin signaling promotes chondrocyte survival under
basal conditions and in response to apoptosis inducers.
Discussion
Understanding mechanisms that control articular cartilage forma-
tion and maintenance is of significance to cartilage tissue engineer-
ing and the prevention and treatment of diseases affecting articular
cartilage. In regards to cartilage tissue engineering a major unmet
challenge is the generation of a tissue that recapitulates the zonal
organization of normal cartilage. In regards to joint diseases, the
major current deficit is in the lack of therapies for OA, the most
prevalent form of arthritis. The initial lesions in OA are at the
articular surface and once the SZ of cartilage is disrupted, the
chronic cartilage remodeling and degradation process is initiated.
To begin elucidating molecular mechanisms that govern the SZ
phenotype we showed that the chromatin protein HMGB2 is
uniquely expressed in the SZ (17). Aging in humans and mice is
associated with a loss of HMGB2 expression, which correlates with
OA-like cartilage changes andmicewithHmgb2deletion showearly
onset and more severe OA (17). This observation presented a
starting point to further characterize the signaling network in which
HMGB2 operates to control SZ cell survival and function.
The Wnt/-catenin pathway presented a candidate based on a
series of recent observations. Most notably, loss of -catenin
signaling leads to OA-like pathology (27). The first observations in
this study addressed -catenin activation patterns in articular
cartilage. Wnt/-catenin signaling is active at multiple embryonic
stages of joint formation (24). Postnatally, we observed remarkable
similarities between localization of HMGB2 and -catenin.
HMGB2 expression and -catenin activation were found in all
zones of articular cartilage in newborn mice. With joint maturation
both became more restricted to the SZ and both showed an
aging-related loss in the SZ. Although HMGB2 eventually was
completely absent, -catenin was activated in the other cartilage
zones.
To determinemolecular mechanisms related to these similarities
in expression patterns we analyzed functional and physical inter-
actions. Our EMSA data showed that HMGB2 does not directly
bind to regulatory DNA elements but it augments DNA binding of
Lef-1. HMGB2 does not alter the electrophoretic mobility of Lef-1
complexed with oligonucleotides, suggesting that HMGB2 dissoci-
ates from the complex after having provided its architectural
activity (42). Similar results were observed for HMGB1, which
increased the affinity of p53 complexes with oligonucleotides (43).
Transfection of HMGB2 did not activate -catenin responsive
promoters but cotransfection of HMGB2 and -catenin did result
in synergistic activation of Lef-1 responsive promoters. This synergy
was seen in two chondrogenic cell types, including SW1353 chon-
drosarcoma cells and ATDC5 prechondrogenic cells but not in
lineages such as kidney epithelial cells, suggesting other lineage
specific factors mediate this interaction or the difference in both
HMGB2 and HMGB1 between chondrogenic cells and 293T cells
is responsible (Fig. S4).
Physical interaction studies showed there is no direct binding of
HMGB2 and -catenin. However, HMGB2 binds to Lef-1 and the
complex that contains HMGB2, -catenin, Lef-1 and probably
other components leads to enhanced expression of genes contain-
ing Lef-1 binding sites. Mapping of interaction domains revealed
that the HMG domain in Lef-1 is required for HMGB2 binding.
The HMG domain is also responsible for interaction with Notch
intracellular domain (44). Notch1 is expressed in developing artic-
ular cartilage surface (45) in a pattern similar to HMGB2 (17),
indicating that Notch might be involved in Lef1-HMGB2 complex
formation in temporally and spatially specific patterns during
cartilage formation. HMGB2 has been reported to interact with
steroid receptors (46), p53 and p73 (47). Stros et al. reported that
B-box within human HMGB1 required the TKKKFKD motif that
is included in the linker for interaction with p73, whereas A-box
itself can bind p73 (47). It has also been shown that A-box, which
contains the linker region within HMGB1, can interact with p53
(48). Our results demonstrate that the A-box or B-box within
HMGB2 contribute to binding with Lef-1 only when the linker is
present, because A-box, B-box and box deletion mutants did not
bind with Lef-1. HMGB1 can also interact with Lef-1 (Fig. S5).
Considering that HMGB1 is ubiquitously expressed in the nuclei
throughout normal articular cartilage (Fig. S6), we cannot exclude
the possibility that HMGB1 and HMGB2 may function coopera-
tively as coactivators for Wnt/-catenin signaling in the SZ (17).
The findings on interactions between HMGB2 and the Wnt
signaling pathway are similar to a report demonstrating that
HMG-17 was responsive to Wnt/-catenin signaling. HMG-17
forms a chromatin complex with PITX2 to repress PITX2 tran-
scriptional activity. This complex is inactive and switched to an
active transcriptional complex through the interaction of -catenin
with PITX2 (49).
To determine functional consequences of the HMGB2/Lef-1
interaction in a cellular context, we analyzed cell survival and
expression of representative Lef-1 target genes. The conditional
deletion of -catenin by Cre adenovirus infection of chondrocytes
from -catenin floxed mice increased basal and in vitro induced
apoptosis. This observation is consistent with our earlier findings
that Hmgb2 deficient cells are more susceptible to CD95/Fas
mediated apoptosis (17). Inhibition of Wnt proteins promotes
programmed cell death in different types of cancer cells (50, 51). In
human OA cartilage, FrzB-2 is highly expressed and is associated
with chondrocyte apoptosis (52). In Col2a1-ICAT-transgenic mice
in which -catenin signaling is selectively blocked in chondrocytes,
apoptosis is increased (27).
Our results also show that promoters with Lef-1 binding sites
were less responsive toWnt3a treatment inHmgb2/ chondrocytes
compared with WT chondrocytes. Then we analyzed cyclin D1,
Gli3 and Fzd2, three representative and well characterized Lef-1
target genes in cartilage (26, 40, 53). The expression levels of these
genes were reduced by HMGB2 siRNA in chondrocytes. Thus, it is
possible that reduction of these three genes at least in part explains
the increased apoptosis seen in both theHmgb2 deficient mice (17)
and in chondrocytes with deficient -catenin (27).
In conclusion, this study demonstrates similar expression and
activation patterns of HMGB2 and -catenin in articular cartilage
and that a loss of these pathways in the SZ of articular cartilagemay
lead to altered gene expression, cell death and OA-like changes.
Materials and Methods
Mice. The -catenin floxedmice (-cateninflox/flox) with loxP sites in introns 1 and
6 of the -catenin gene (6.129-Ctnnb1tmKem/KnwJ line) and TOPGAL mice
(Tg(Fos-lacZ)34Efu/J line) (29)werepurchased fromthe JacksonLaboratory.Mice
were used according to protocols approved by the Institutional Animal Care and
Use Committee at The Scripps Research Institute.
Plasmid Construction. The HMGB2 deletion constructs were prepared by PCR
amplification of full-length murine HMGB2 cDNA and cloned into pcDNA3-flag
vector after themapping of A-box and B-boxwithin human HMGB2 (54). pGEX-
HMGB2andpGEX-HMGB1were constructedby subcloningofmurineHMGB2or
humanHMGB1 intopGEX(Promega), respectively.pGEX--cateninwasprovided
by X. He (Harvard Medical School, Boston) and pGEX-Lef-1 by M.R. Stallcup
(University of Southern California, Los Angeles).
GST Pull-Down Assay. The wild-type and deletion mutants of HMGB2 and Lef-1
were invitrotranscribed/translatedwiththeTNTreticulocyte lysatekit (Promega)
in the presence of [35S]methionine. GST-null, GST-HMGB2, GST-Lef-1, or GST--
catenin proteins were produced in E. coli and purified, and then incubated
overnight at 4 °C rotating with the 35S-met-labeled proteins in PC100ME
buffer (55). After extensive washes, we added SDS loading buffer to the beads,
boiled them, and separated the supernatant on SDS/PAGE gels. As a positive
control, theamountof 35S-met-labeledprotein loadedwas20%of the input. The
gels were dried and then exposed to X-ray film.
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Electrophoretic Mobility-Shift Assay (EMSA). Preparation of DNA for EMSAwith
32P-labeled duplex oligonucleotide probes for CD1, CD1TOP and CD1FOP was
described earlier (36). We also generated synthetic duplex oligonucleotides en-
compassing regions evolutionarily conserved in the c-Jun promoter (37). The
binding reaction contained 40,000 cpm of 32P-labeled DNA that was incubated
with nuclear extracts from SW1353 cells with or without transfection of HA-
tagged Lef-1 expression vector (gift from P.K. Vogt, The Scripps Research Insti-
tute) in the presence of purified calf thymus HMGB2 protein (Shino-Test), fol-
lowingGel ShiftAssaySystemsProtocol (Promega).DNA-proteincomplexeswere
electrophoresed in 6%DNA retardation gel (Invitrogen) and visualized by auto-
radiography.
Quantitative PCR. Total RNA was extracted and oligo(dT)-primed cDNA was
prepared from 500 ng of total RNA by using SuperScript III (Invitrogen). The
resulting cDNAs were analyzed by using the SYBR green system for quantitative
analysis of specific transcripts as described in ref. 56. All mRNA expression data
were normalized to GAPDH expression in the same sample. The primers used in
real-time PCR are listed in SI Text.
Apoptosis Induction and Analysis in Vitro. Chondrocytes were prepared from
5-day-old-cateninfloxedmice (-cateninflox/flox) as described in ref. 57. The cells
wereplated in6-well platesat semiconfluence, infectedwithadenovirusexpress-
ingbothCre recombinaseandgreenfluorescentprotein (GFP) (Adv-Cre-GFP)and
cultured for 72 h. We used an E1/E3-deleted, replication-incompetent, serotype
5adenovirus-expressingCre recombinaseandGFPunder control of the cytomeg-
alovirus (CMV)promoter.MediumwaschangedtoDMEM/F12with0.5%FBSand
chondrocytes were stimulated with NA/LE hamster anti-mouse CD95 antibody
(BD PharMingen) and proteasome inhibitor MG132 (Sigma) for 12 h, which
induces apoptosis in articular chondrocytes (58). Cells were incubatedwith FITC-
labeledannexinV(BDPharMingen)orpropidiumiodide(Sigma)andanalyzedon
a BD FACSCalibur as described in ref. 17.
Statistical Analysis. Results are expressed as mean standard deviation. Statis-
tical comparisonbetweengenotypes or treatment groupswas performedwith a
two-tailed Student’s t test. P values0.05 were considered significant.
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